These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20888784)

  • 1. Comparability assessments of process and product changes made during development of two different monoclonal antibodies.
    Lubiniecki A; Volkin DB; Federici M; Bond MD; Nedved ML; Hendricks L; Mehndiratta P; Bruner M; Burman S; Dalmonte P; Kline J; Ni A; Panek ME; Pikounis B; Powers G; Vafa O; Siegel R
    Biologicals; 2011 Jan; 39(1):9-22. PubMed ID: 20888784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparability testing of a humanized monoclonal antibody (Synagis) to support cell line stability, process validation, and scale-up for manufacturing.
    Schenerman MA; Hope JN; Kletke C; Singh JK; Kimura R; Tsao EI; Folena-Wasserman G
    Biologicals; 1999 Sep; 27(3):203-15. PubMed ID: 10652176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray-based gene expression analysis as a process characterization tool to establish comparability of complex biological products: scale-up of a whole-cell immunotherapy product.
    Wang M; Senger RS; Paredes C; Banik GG; Lin A; Papoutsakis ET
    Biotechnol Bioeng; 2009 Nov; 104(4):796-808. PubMed ID: 19591186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site transfer and process validation in case of Herceptin API.
    Kuhne W
    Dev Biol (Basel); 2003; 113():47-50. PubMed ID: 14620851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
    Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggregates in monoclonal antibody manufacturing processes.
    Vázquez-Rey M; Lang DA
    Biotechnol Bioeng; 2011 Jul; 108(7):1494-508. PubMed ID: 21480193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic, pharmacodynamic and immunogenicity comparability assessment strategies for monoclonal antibodies.
    Putnam WS; Prabhu S; Zheng Y; Subramanyam M; Wang YM
    Trends Biotechnol; 2010 Oct; 28(10):509-16. PubMed ID: 20691488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid whole monoclonal antibody analysis by mass spectrometry: An ultra scale-down study of the effect of harvesting by centrifugation on the post-translational modification profile.
    Reid CQ; Tait A; Baldascini H; Mohindra A; Racher A; Bilsborough S; Smales CM; Hoare M
    Biotechnol Bioeng; 2010 Sep; 107(1):85-95. PubMed ID: 20506289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of gene therapy products and the impact of manufacturing changes on product comparability.
    Simek SL
    Dev Biol (Basel); 2005; 122():139-44. PubMed ID: 16375258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [EMABling antibodies: from feto-maternal allo-immunisation prophylaxis to chronic lymphocytic leukaemia therapy].
    Urbain R; Teillaud JL; Prost JF
    Med Sci (Paris); 2009 Dec; 25(12):1141-4. PubMed ID: 20035694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans.
    Omtvedt LA; Royle L; Husby G; Sletten K; Radcliffe CM; Harvey DJ; Dwek RA; Rudd PM
    Arthritis Rheum; 2006 Nov; 54(11):3433-40. PubMed ID: 17075835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing.
    Trexler-Schmidt M; Sargis S; Chiu J; Sze-Khoo S; Mun M; Kao YH; Laird MW
    Biotechnol Bioeng; 2010 Jun; 106(3):452-61. PubMed ID: 20178122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
    Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
    Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
    Schüle S; Friess W; Bechtold-Peters K; Garidel P
    Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing biological products and assessing comparability following manufacturing changes.
    Chirino AJ; Mire-Sluis A
    Nat Biotechnol; 2004 Nov; 22(11):1383-91. PubMed ID: 15529163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparability and monitoring immunogenic N-linked oligosaccharides from recombinant monoclonal antibodies from two different cell lines using HPLC with fluorescence detection and mass spectrometry.
    Kilgore BR; Lucka AW; Patel R; Andrien BA; Dhume ST
    Methods Mol Biol; 2008; 446():333-46. PubMed ID: 18373268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Process-scale purification from cell culture supernatants: monoclonal antibodies.
    Ostlund C; Borwell P; Malm B
    Dev Biol Stand; 1987; 66():367-75. PubMed ID: 3108053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of immunoglobulin G glycosylation in monoclonal and polyclonal species by electrospray and matrix-assisted laser desorption/ionization mass spectrometry.
    Saba JA; Kunkel JP; Jan DC; Ens WE; Standing KG; Butler M; Jamieson JC; Perreault H
    Anal Biochem; 2002 Jun; 305(1):16-31. PubMed ID: 12018942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal lysine variants in fully human monoclonal antibodies: investigation of test methods and possible causes.
    Dick LW; Qiu D; Mahon D; Adamo M; Cheng KC
    Biotechnol Bioeng; 2008 Aug; 100(6):1132-43. PubMed ID: 18553400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of an industrial affinity process used in the manufacturing of digoxin-specific polyclonal Fab fragments.
    Thillaivinayagalingam P; O'Donovan K; Newcombe AR; Keshavarz-Moore E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):88-96. PubMed ID: 16720112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.